Retatrutide: Phase 2 Trial The Phase 2 trial enrolled 338 adults with obesity
People with thyroid cancer were matched with up to 20 control participants without thyroid cancer by age, sex and diabetes duration
Redox homeostasis maintained by GPX4 facilitates STING activation
(2012) The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors
If side effects are problematic, your doctor can discuss alternatives, including: Dose adjustment or slower titration Switching to a different GLP-1 receptor agonist Alternative diabetes medications with different mechanisms of action Additional treatments to manage specific symptoms According to NICE guidance on type 2 diabetes management (NG28), treatment decisions should be individualised, balancing efficacy, side effects, patient preferences, and overall quality of life